Fermi prices $375 million convertible notes offering

Fermi (FRMI) priced $375m of 5.00% convertible senior notes due 2031, with an additional $56.25m option, expecting net proceeds of ~$362.25m (~$416.81m if fully exercised). The deal implies a ~30% conversion-price premium (~$9.52 vs $7.32 close on July 9) and shifts funding toward general corporate purposes after allocating ~$30m to capped call transactions. While framed as potentially undervalued (fair value $9.78), the company’s levered free cash flow is deeply negative (‑$1.05B LTM) and the financial health score is rated “WEAK,” suggesting the raise is a credit/liquidity support action.

Analysis

This is a capital-structure event first and a business update second. The equity is effectively being refinanced with a long-dated instrument that pushes dilution out in time, but the market usually treats that as an implicit admission that internal cash generation is not funding the buildout; that keeps a valuation discount on the stock until there is clear evidence of project monetization. The capped call reduces near-term dilution at the conversion strike, but it does not remove the overhang: convert buyers typically hedge by shorting stock, which can cap rallies and compress upside into the next 1-3 months.

The main beneficiaries are the non-equity providers getting paid on the project execution path. PRIM should be the cleaner second-order winner because its economics are fee-based and less dependent on FRMI’s balance sheet, while FRMI’s shareholders are taking the residual risk of construction delays, permitting slippage, and incremental funding needs. Any weakness in power prices, data-center demand, or financing conditions would hit FRMI twice: lower project optionality and a tougher refinancing backdrop.

Contrarian view: the issuance can be read as survival runway rather than distress if management uses it to bridge to major milestones or contracted cash flows. The stock is most vulnerable over days to weeks while the deal is digested; over 1-3 months, the key question is whether project updates prove the financing was proactive rather than reactive. The thesis is falsified if FRMI secures external project financing or signed off-take that materially improves liquidity, or if the stock can hold above the conversion zone after the new notes are placed.

Key Decisions for Investors

• Short FRMI on post-issue strength over the next 1-3 weeks; target a fade back toward pre-rally levels as convert hedging supply hits the tape. Risk/reward improves if borrow is available and the stock fails to hold above the deal-clearing range.
• Pair trade: long PRIM / short FRMI for 1-3 months to isolate project-execution revenue versus balance-sheet risk. PRIM is the cleaner beneficiary of buildout spend; FRMI carries dilution and financing risk.
• Avoid chasing FRMI calls into the financing unless there is a separate catalyst showing contract monetization or project financing. The convert structure creates a natural ceiling near the conversion zone, limiting upside unless fundamentals re-rate sharply.
• Set a watch item on FRMI for any announcement of long-term power contracts, asset-level debt, or equity financing at a higher price. Those events would invalidate the short thesis and could force a sharp cover.